Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
Keywords:
Safety, Efficacy, Antithrombotic Strategies, Atrial Fibrillation, Percutaneous Coronary InterventionAbstract
Background: The landscape of antithrombotic strategies in patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) has evolved significantly over the past decade, driven by the need to balance the prevention of thromboembolic events with the risk of bleeding. Literature Review: The literature on antithrombotic strategies for patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) reveals a nuanced landscape characterized by evolving treatment regimens aimed at balancing thromboembolic prevention and bleeding risk. The initial exploration identified significant gaps in the understanding of optimal therapies for AF patients post-PCI, highlighting the need for evidence-based approaches. Subsequent systematic reviews and meta-analyses. Conclusion: In conclusion, the evolving body of literature reflects a significant shift towards optimizing antithrombotic strategies for AF patients undergoing PCI. The consensus points to the need for individualized approaches that consider both thromboembolic and bleeding risks, with a growing preference for dual therapy involving NOACs. As research continues to advance, it is imperative that clinical guidelines are updated to reflect these findings, ensuring that patient care is informed by the most current evidence.
References
Jang, S. W., Rho, T. H., Kim, D. B., Joo Cho, E., Kwon, B. J., Park, H. J., Shin, W. S., Kim, J. H., Lee, J. M., Moon, K. W., Oh, Y. S., Yoo, K. D., Youn, H. J., Lee, M. Y., Chung, W. S., Seung, K. B., & Kim, J. H., 2011. Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation After Coronary Stent Implantation. ncbi.nlm.nih.gov
Gong, X., Tang, S., Li, J., Zhang, X., Tian, X., & Ma, S., 2017. Antithrombotic therapy strategies for atrial fibrillation patients undergoing percutaneous coronary intervention: A systematic review and network meta-analysis. ncbi.nlm.nih.gov
Agasthi, P., Z. Lee, J., Harika Pujari, S., S. Tseng, A., Shipman, J., Almader‐Douglas, D., Ashraf, H., Mookadam, F., David Fortuin, F., Beohar, N., Arsanjani, R., & Mulpuru, S., 2020. Safety and efficacy of direct oral anticoagulants compared to Vitamin K antagonists postpercutaneous coronary interventions in patients with atrial fibrillation: A systematic review and meta‐analysis. ncbi.nlm.nih.gov
Chua, S. K., Chen, L. C., Shyu, K. G., Cheng, J. J., Hung, H. F., Chiu, C. Z., & Lin, C. M., 2020. Antithrombotic Strategies in Patients with Atrial Fibrillation Following Percutaneous Coronary Intervention: A Systemic Review and Network Meta-Analysis of Randomized Controlled Trials. ncbi.nlm.nih.gov
Liang, B., Zhu, Y. C., & Gu, N., 2022. Comparative Safety and Efficacy of Eight Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention. ncbi.nlm.nih.gov
Greco, A., Laudani, C., Rochira, C., & Capodanno, D., 2023. Antithrombotic Management in AF Patients Following Percutaneous Coronary Intervention: A European Perspective. ncbi.nlm.nih.gov
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Untung, Rosita (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
